News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
44,902 Results
Type
Article (1804)
Company Profile (30)
Press Release (43068)
Section
Business (11877)
Career Advice (68)
Deals (1993)
Drug Delivery (3)
Drug Development (6302)
Employer Resources (3)
FDA (983)
Job Trends (894)
News (20604)
Policy (1497)
Tag
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
2024 Pharm Country Standard (1)
Academia (197)
Adcomms (3)
Allergies (9)
Alliances (2686)
ALS (3)
Alzheimer's disease (99)
Antibody-drug conjugate (ADC) (11)
Approvals (990)
Artificial intelligence (7)
Autoimmune disease (1)
Bankruptcy (15)
Best Places to Work (757)
BIOSECURE Act (4)
Biosimilars (4)
Biotechnology (21)
Bladder cancer (3)
Brain cancer (1)
Breast cancer (8)
Cancer (138)
Cardiovascular disease (15)
Career advice (54)
Career pathing (1)
CAR-T (19)
Cell therapy (50)
Cervical cancer (1)
Clinical research (5089)
Collaboration (41)
Compensation (15)
Complete response letters (1)
COVID-19 (203)
CRISPR (4)
C-suite (14)
Cystic fibrosis (8)
Data (159)
Diabetes (13)
Diagnostics (340)
Drug discovery (4)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (4810)
Editorial (2)
Employer resources (3)
Events (8514)
Executive appointments (56)
FDA (1059)
Featured Employer (5)
Funding (56)
Gene editing (10)
Gene therapy (44)
GLP-1 (48)
Government (169)
Guidances (2)
Healthcare (1347)
IgA nephropathy (2)
Immunology and inflammation (3)
Infectious disease (210)
Inflammatory bowel disease (13)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (3)
Interviews (9)
IPO (1173)
IRA (1)
Job creations (179)
Job search strategy (52)
Kidney cancer (1)
Labor market (2)
Layoffs (15)
Legal (257)
Liver cancer (7)
Lung cancer (26)
Lymphoma (14)
Management (1)
Manufacturing (11)
Medical device (649)
Medtech (649)
Mergers & acquisitions (846)
Metabolic disorders (28)
Multiple sclerosis (1)
Neurodegenerative disease (5)
Neuroscience (116)
NextGen: Class of 2025 (451)
Non-profit (300)
Northern California (192)
Now hiring (1)
Obesity (18)
Opinion (3)
Ovarian cancer (1)
Pain (9)
Pancreatic cancer (6)
Parkinson's disease (7)
Patents (12)
Patient recruitment (7)
Peanut (4)
People (3720)
Pharmaceutical (2)
Phase I (1735)
Phase II (2190)
Phase III (1817)
Pipeline (77)
Policy (7)
Postmarket research (224)
Preclinical (576)
Press Release (3)
Prostate cancer (5)
Radiopharmaceuticals (12)
Rare diseases (24)
Real estate (350)
Recruiting (2)
Regulatory (1190)
Reports (7)
Research institute (157)
Resumes & cover letters (6)
RSV (2)
Schizophrenia (3)
Series A (10)
Series B (2)
Service/supplier (2)
Sickle cell disease (3)
Southern California (158)
Special edition (1)
Spinal muscular atrophy (5)
Sponsored (5)
Startups (216)
Supply chain (2)
United States (1423)
Vaccines (33)
Webinars (1)
Weight loss (5)
Women's health (1)
Worklife (1)
Date
Last 7 days (50)
Last 30 days (151)
Last 365 days (2726)
2025 (717)
2024 (2726)
2023 (3079)
2022 (4383)
2021 (5195)
2020 (4403)
2019 (3390)
2018 (2229)
2017 (2015)
2016 (1838)
2015 (2122)
2014 (1373)
2013 (1179)
2012 (1253)
2011 (1384)
2010 (1215)
Location
Africa (27)
Arizona (7)
Asia (2530)
Australia (421)
California (447)
Canada (161)
China (39)
Colorado (21)
Connecticut (20)
Delaware (17)
Europe (7230)
Florida (48)
Georgia (6)
Idaho (1)
Illinois (24)
India (2)
Indiana (6)
Japan (14)
Kansas (3)
Kentucky (1)
Maryland (66)
Massachusetts (242)
Michigan (7)
Minnesota (42)
Mississippi (1)
Missouri (50)
Nevada (9)
New Hampshire (6)
New Jersey (89)
New Mexico (1)
New York (73)
North Carolina (63)
Northern California (192)
Ohio (7)
Oklahoma (1)
Oregon (1)
Pennsylvania (117)
Puerto Rico (2)
Rhode Island (2)
South America (55)
Southern California (158)
Tennessee (6)
Texas (48)
Utah (6)
Virginia (6)
Washington D.C. (2)
Washington State (24)
Wisconsin (1)
44,902 Results for "1st biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Drug Development
1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors
1ST Biotherapeutics, Inc. announced the first patient dosing in the clinical Phase I/II trial evaluating FB849 in patients with advanced solid tumors.
December 14, 2023
·
1 min read
Press Releases
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
February 17, 2025
·
9 min read
Press Releases
Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
March 24, 2025
·
8 min read
Press Releases
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
3 min read
Press Releases
FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium
February 14, 2025
·
1 min read
Press Releases
FORE Biotherapeutics to Present Two Plixorafenib Abstracts at the American Association for Cancer Research Annual Meeting 2025
March 25, 2025
·
2 min read
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Business
1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab)
1ST Biotherapeutics, Inc. announced a Clinical Trial Collaboration and Supply Agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, to evaluate FB849 in combination with MSD’s anti-PD-1 therapy KEYTRUDA® in a Phase I/II clinical trial for the treatment of patients with advanced solid tumors.
September 19, 2023
·
2 min read
Press Releases
Artiva Biotherapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights
March 24, 2025
·
8 min read
1 of 4,491
Next
